| |||||||||
Former Names BALB/cAnBomUrd-PhexUrd (Changed: 15-DEC-04 ) Type Coisogenic; Mutant Strain; Spontaneous Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Generation F64+20+F7 (06-DEC-07) Appearance
albino, small, shortened hindlimbs and tail, possible circling
Related Genotype: A/A Tyrp1b/Tyrp1b Tyrc/Tyrc PhexHyp-Duk/Y male
albino, may exhibit small size, shortened hindlimbs and tail, circling
Related Genotype: A/A Tyrp1b/Tyrp1b Tyrc/Tyrc PhexHyp-Duk/+ female
albino, unaffected
Related Genotype: A/A Tyrp1b/Tyrp1b Tyrc/Tyrc +/+ or +/YDescription
This mutant offers a model for X-linked dominant hypophosphatemic rickets. The serum phosphorus (2.95 mg/dL) in hemizygous males is lower than that found in hypophosphatemia, hypophosphatemia 2 Jackson, or gyro hemizygous males. The skeletal defects include shortened long bones and craniofacial defects and hemizygous males have cochlear degeneration and a heightened auditory brainstem response threshold, higher than that in other Phex mutants. The heightened ABR threshold is dependent upon a modifier that is absent in BALB/cByJ. Consistent with vestibular dysfunction, approximately half of the hemizygous males and some of the heterozygous females display circling behavior, and in hemizygous males head bobbing or unstable gait have also been noted. Hemizygous males are mildly growth retarded, with a squared and shortened body, and shortened hind limbs and tail. While some heterozygous females display circling and growth retardation, not all do and they are more difficult to distinguish from wildtype than are heterozygous hypophosphatemia 2 Jackson heterozygotes.Development
The Hyp-Duk mutation arose spontaneously in a BALB/cAnBomUrd subline bearing a nude (Foxn1) mutation in the laboratory of Susan Poulton at Duke University. In Sept 1998 BALB/AnBomUrd mice segregating for both nude and the Hyp-Duk mutation at generation F64 were received at The Jackson Laboratory, sibling bred, and re-derived. Through selective sibling crosses the nude mutation was bred out of this strain and the Hyp-Duk mutation maintained. The strain continued to be maintained through sibling inbreeding.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| Considerations for Choosing Controls | ||
Strains carrying PhexHyp-Duk allele
005068 B6.C-PhexHyp-Duk/J 005852 BALB/c-PhexHyp-Duk/J View Strains carrying PhexHyp-Duk (2 strains)
Strains carrying other alleles of Phex
000528 B6.Cg-PhexHyp/J 003950 C57BL/6-PhexHyp-2J/J View Strains carrying other alleles of Phex (2 strains)
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms
Hypophosphatemic Rickets, X-Linked Dominant - Models with phenotypic similarity to human disease where etiologies involve orthologs.1
1 Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
PhexHyp-Duk/Phex+
involves: BALB/cAnBomUrd
- behavior/neurological phenotype
- circling (MGI Ref ID J:88352)
- some but not all females showed circling behavior
- growth/size phenotype
- postnatal growth retardation (MGI Ref ID J:88352)
- some but not all females are mildly growth retarded in overall body size with a squared trunk
- unlike PhexHyp-2J it is not easy to distinguish between heterozygous females and wild-type females
- limbs/digits/tail phenotype
- abnormal hindlimb morphology (MGI Ref ID J:88352)
- some but not all females have shortened hind limbs
- short tail (MGI Ref ID J:88352)
- some but not all females have a shortened tail
- hearing/vestibular/ear phenotype
- circling (MGI Ref ID J:88352)
- some but not all females showed circling behavior
PhexHyp-Duk/Y
involves: BALB/cAnBomUrd
- adipose tissue phenotype
- decreased adipose tissue amount (MGI Ref ID J:88352)
- a significant increase in lean body mass is seen compared to controls
- behavior/neurological phenotype
- abnormal gait (MGI Ref ID J:132678)
- in some hemizygotes
- circling (MGI Ref ID J:88352)
- 11 out of 20 males showed circling behaviour
- head bobbing (MGI Ref ID J:132678)
- in some hemizygotes
- craniofacial phenotype
- abnormal craniofacial bone morphology (MGI Ref ID J:88352)
- abnormal temporal bone morphology (MGI Ref ID J:88352)
- the temporal bone surrounding the cochlea is thickened with areas of non-mineralization
- short maxilla (MGI Ref ID J:88352)
- the length of the upper jaw is reduced
- small skull (MGI Ref ID J:88352)
- at 12 weeks the skull is significantly shorter in length with a shorter nose length and lower areal bone mineral density compared to controls
- skull width and skull to nose length ratio are unaffected
- growth/size phenotype
- decreased body weight (MGI Ref ID J:88352)
- all males have significantly lower body weights, ~25% less than controls
- postnatal growth retardation (MGI Ref ID J:88352)
- all males are mildly growth retarded in overall body size with a squared trunk
- hearing/vestibular/ear phenotype
- *normal* hearing/vestibular/ear phenotype (MGI Ref ID J:132678)
- at 40 days of age the cells of the spiral ganglion and the organ of Corti remain intact
- abnormal inner ear morphology (MGI Ref ID J:88352)
- abnormal cochlea morphology (MGI Ref ID J:88352)
- endolymph volume appears larger in the cochleas, resulting in increased scala media, decreased scala vestibule and displacement of Reissner's membrane which separates these
- abnormal scala tympani morphology (MGI Ref ID J:88352)
- a precipitate is found in the scala tympani of the cochlea
- distended Reissner membrane (MGI Ref ID J:132678)
- organ of Corti degeneration (MGI Ref ID J:88352)
- degeneration is obvious in the apical turn of the cochlea but decreases towards the base
- abnormal otic capsule morphology (MGI Ref ID J:132678)
- the otic bony capsule of hemizygotes is thickened and surrounded by non-mineralized bone at around 25 days of age
- abnormal saccule morphology (MGI Ref ID J:132678)
- in some instances at 90 days of age the saccule is ruptured apparently due to hydrops
- circling (MGI Ref ID J:88352)
- 11 out of 20 males showed circling behaviour
- decreased brainstem auditory evoked potential (MGI Ref ID J:88352)
- mean auditory brainstem response thresholds are significantly higher than controls
- mean auditory brainstem response thresholds are also significantly higher than other Phex male mutants (PhexHyp, PhexHyp-2J, Gy)
- this difference from other Phex mutants but not from wild-type controls disappeared when PhexHyp-Duk was outcrossed to BALB/cByJ
- ABR assessment shows that at 21 days of age most hemizygotes have mild to moderate unilateral hearing loss, by 25 days of age the majority have bilateral hearing loss exceeding that of controls by 30 dB, and hearing loss is progressive with onset of inner ear dysfunction centered between 25 and 30 days of age
- ear inflammation (MGI Ref ID J:132678)
- some hemizygotes show mild apical hydrops at 21 to 25 days of age, but this is not accompanied by hair cell loss and the endolymphatic duct appears normal along its entire course with no occlusion or dilation
- by 40 days of age most hemizygotes have severe endolymphatic hydrops with distension of Reissner's membrane
- by 90 days of age severe hydrops in all parts of the labyrinth is found and Reissner's membrane is displaced
- increased susceptibility to otitis media (MGI Ref ID J:132678)
- head bobbing (MGI Ref ID J:132678)
- in some hemizygotes
- unilateral deafness (MGI Ref ID J:132678)
- homeostasis/metabolism phenotype
- decreased circulating potassium level (MGI Ref ID J:88352)
- at 6 weeks of age serum PO4 levels are significantly lower than controls
- hypocalcemia (MGI Ref ID J:88352)
- at 6 weeks of age serum Ca2+ are significantly decreased compared to controls
- limbs/digits/tail phenotype
- abnormal hindlimb morphology (MGI Ref ID J:88352)
- shortened hind limbs are seen
- abnormal skeleton extremities morphology (MGI Ref ID J:88352)
- abnormal patella morphology (MGI Ref ID J:88352)
- growth plates of the knee are thickened and irregular
- decreased length of long bones (MGI Ref ID J:88352)
- the long bones are shortened
- short femur (MGI Ref ID J:88352)
- short fibula (MGI Ref ID J:88352)
- the fibula is shortened and splayed
- short tibia (MGI Ref ID J:88352)
- the tibia is shortened and splayed
- increased diameter of long bones (MGI Ref ID J:88352)
- the long bones are thickened
- short tail (MGI Ref ID J:88352)
- skeleton phenotype
- abnormal craniofacial bone morphology (MGI Ref ID J:88352)
- abnormal temporal bone morphology (MGI Ref ID J:88352)
- the temporal bone surrounding the cochlea is thickened with areas of non-mineralization
- short maxilla (MGI Ref ID J:88352)
- the length of the upper jaw is reduced
- small skull (MGI Ref ID J:88352)
- at 12 weeks the skull is significantly shorter in length with a shorter nose length and lower areal bone mineral density compared to controls
- skull width and skull to nose length ratio are unaffected
- abnormal skeleton extremities morphology (MGI Ref ID J:88352)
- abnormal patella morphology (MGI Ref ID J:88352)
- growth plates of the knee are thickened and irregular
- decreased length of long bones (MGI Ref ID J:88352)
- the long bones are shortened
- short femur (MGI Ref ID J:88352)
- short fibula (MGI Ref ID J:88352)
- the fibula is shortened and splayed
- short tibia (MGI Ref ID J:88352)
- the tibia is shortened and splayed
- increased diameter of long bones (MGI Ref ID J:88352)
- the long bones are thickened
- decreased bone density (MGI Ref ID J:88352)
- between 6 and 40 weeks of age under-mineralized bone is present throughout the body
- disorganized long bone epiphyseal plate (MGI Ref ID J:88352)
- disorganized femoral growth plates
- nervous system phenotype
- cochlear ganglion degeneration (MGI Ref ID J:88352)
- degeneration is obvious in the apical turn of the cochlea but decreases towards the base
- at 90 days of age spiral ganglion degeneration in most turns of the cochlea is found, although the hair cells are largely preserved
- immune system phenotype
- ear inflammation (MGI Ref ID J:132678)
- some hemizygotes show mild apical hydrops at 21 to 25 days of age, but this is not accompanied by hair cell loss and the endolymphatic duct appears normal along its entire course with no occlusion or dilation
- by 40 days of age most hemizygotes have severe endolymphatic hydrops with distension of Reissner's membrane
- by 90 days of age severe hydrops in all parts of the labyrinth is found and Reissner's membrane is displaced
- increased susceptibility to otitis media (MGI Ref ID J:132678)
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
PhexHyp-Duk/Y
B6.C-PhexHyp-Duk/J
- behavior/neurological phenotype
- *normal* behavior/neurological phenotype (MGI Ref ID J:132678)
- startle response is normal and no head-bobbing or circling are seen
- growth/size phenotype
- decreased body size (MGI Ref ID J:132678)
- craniofacial phenotype
- abnormal skull morphology (MGI Ref ID J:132678)
- slightly abnormal shape
- skeleton phenotype
- abnormal skull morphology (MGI Ref ID J:132678)
- slightly abnormal shape
- hearing/vestibular/ear phenotype
- *normal* hearing/vestibular/ear phenotype (MGI Ref ID J:132678)
- startle response is normal and no head-bobbing or circling are seen
- ABR recordings at 21 to 50 days of age are normal, cochlear ducts at 4 months of age do not show endolymphatic hydrops or spiral ganglion cell degeneration
- abnormal otic capsule morphology (MGI Ref ID J:132678)
- by one month of age the otic capsule is markedly thickened and surrounded by non-mineralized bone, similar to that seen on the BALB/cUrd background
- decreased brainstem auditory evoked potential (MGI Ref ID J:132678)
- although on the C67BL/6J background the ABR threshold is normal in younger mice, at over 2 months of age some unilateral increase in threshold of 10-15 dB SPL above normal is found so the hearing loss is much less severe than on the BALB/cUrd background
| Allele Symbol | PhexHyp-Duk | ||
|---|---|---|---|
| Allele Name | hypophosphatemia, Duke | ||
| Allele Type | Spontaneous | ||
| Strain of Origin | CAnBomUrd.Cg-Foxn1 | ||
| Gene Symbol and Name | Phex, phosphate regulating gene with homologies to endopeptidases on the X chromosome (hypophosphatemia, vitamin D resistant rickets) | ||
| Chromosome | X | ||
| Gene Common Name(s) | Gy; HPDR; HPDR1; HYP; HYP1; Hyp; PEX; XLH; gyro; hypophosphatemia; | ||
| Molecular Note | Genomic PCR and Southern blot analysis indicated a deletion of at least 30 kb containing exons 13 and 14 of the Phex gene. | ||
This strain will not have a genotyping protocol or one is not currently available.
Helpful Links
Optimizing PCR Protocols
Lorenz-Depiereux B; Guido VE; Johnson KR; Zheng QY; Gagnon LH; Bauschatz JD; Davisson MT; Washburn LL; Donahue LR; Strom TM; Eicher EM. 2004. New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice. Mamm Genome 15(3):151-61. [PubMed: 15029877] [MGI Ref ID J:88352]
PhexHyp-Duk relatedMegerian CA; Semaan MT; Aftab S; Kisley LB; Zheng QY; Pawlowski KS; Wright CG; Alagramam KN. 2008. A mouse model with postnatal endolymphatic hydrops and hearing loss. Hear Res 237(1-2):90-105. [PubMed: 18289812] [MGI Ref ID J:132678]
Colony Maintenance
Diet Information LabDiet® 5K52/5K67
This strain is currently Under Development for Cryopreservation Repository.
To register your interest in this strain go to the Strain Interest Form.
Estimated Available for Sale Date:
Please note: Estimated available for sale dates are provided to keep customers better informed on strains under development. Please note that our Colony Managers routinely monitor the target date and edit it based on breeding performance and other factors. The length of time it takes to make a new strain available for sale depends on genotype, age, number of animals sent by the Donating Investigator, breeding performance, additional strain development (backcrossing, making homozygous), and anticipated demand for the strain/interest registered.
View All Strains Under Development and On Hold
| Standard Supply | Under Development for Cryopreservation Repository |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.